Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Therapeutic angiogenesis for heart failure

Nature Medicine volume 5, pages 491–492 (1999)Cite this article

Abstract

A new study answers one set of questions, but raises many more, about the potential use of specific VEGF isoforms to promote re-vascularization for ischemic cardiomyopathy (pages 495-502).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Observations by Carmeliet et al. in mice with restricted VEGF-A isoforms expression suggest new application for therapeutic angiogenesis:

References

  1. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439 (1996).

    Article  CAS  Google Scholar 

  2. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439– 442 (1996).

    Article  CAS  Google Scholar 

  3. Takeshita, S. et al. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93, 662–670 (1994).

    Article  CAS  Google Scholar 

  4. Takeshita, S. et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75, 487– 502 (1996).

    CAS  PubMed  Google Scholar 

  5. Isner, J.M. et al. Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165. Lancet 348, 370–374 (1996).

    Article  CAS  Google Scholar 

  6. Baumgartner, I. et al. Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114–1123 (1998).

    Article  CAS  Google Scholar 

  7. Isner, J.M. et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results . J. Vasc. Surg. 28, 964 –975 (1998).

    Article  CAS  Google Scholar 

  8. Pearlman, J.D. et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1, 1085–1089 (1995).

    Article  CAS  Google Scholar 

  9. Hariawala, M. et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts . J. Surg. Res. 63, 77–82 (1996).

    Article  CAS  Google Scholar 

  10. Mack, C.A. et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the conplementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115, 168–176 (1998).

    Article  CAS  Google Scholar 

  11. Losordo, D.W. et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800–2804 (1998).

    Article  CAS  Google Scholar 

  12. White, F.C., Carroll, S.M., Magnet, A. & Bloor, C.M. Coronary collateral development in swine after coronary artery occlusion. Circ. Res. 71, 1490–1500 (1992).

    Article  CAS  Google Scholar 

  13. Takeshita, S. et al. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation 95, 805–808 (1997).

    Article  CAS  Google Scholar 

  14. Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J. & Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031–26037 (1992).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Departments of Medicine (Cardiology, Vascular Medicine) and Biomedical Research, St. Elizabeth's Medical Center/Tufts University School of Medicine, Boston, Massachusetts St. Elizabeth's Medical Center, 736 Cambridge St., Boston, 02135, Massachusetts, USA

    Jeffrey M. Isner & Douglas W. Losordo

Authors
  1. Jeffrey M. Isner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas W. Losordo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Isner, J., Losordo, D. Therapeutic angiogenesis for heart failure. Nat Med 5, 491–492 (1999). https://doi.org/10.1038/8374

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/8374

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing